Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Deamination of Glutamine is a Prerequisite for Optimal Asparagine Deamination by Asparaginases In Vivo (CCG-1961)

EDUARD H. PANOSYAN, RITA S. GRIGORYAN, IOANNIS A. AVRAMIS, NITA L. SEIBEL, PAUL S. GAYNON, STUART E. SIEGEL, HOWARD J. FINGERT and VASSILIOS I. AVRAMIS
Anticancer Research March 2004, 24 (2C) 1121-1126;
EDUARD H. PANOSYAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RITA S. GRIGORYAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IOANNIS A. AVRAMIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NITA L. SEIBEL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PAUL S. GAYNON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STUART E. SIEGEL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HOWARD J. FINGERT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VASSILIOS I. AVRAMIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 24 no. 2C 1121-1126
PMID 
15154634

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received January 13, 2004
  • Accepted March 3, 2004
  • Published online March 1, 2004.

Copyright & Usage 
Copyright© 2004 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. EDUARD H. PANOSYAN1,
  2. RITA S. GRIGORYAN1,
  3. IOANNIS A. AVRAMIS1,
  4. NITA L. SEIBEL2,
  5. PAUL S. GAYNON1,3,4,
  6. STUART E. SIEGEL1,3,4,
  7. HOWARD J. FINGERT5,* and
  8. VASSILIOS I. AVRAMIS1,3,4
  1. 1Childrens Hospital Los Angeles, Los Angeles, CA
  2. 2Children's National Medical Center, Washington D.C.
  3. 3USC Keck School of Medicine, Los Angeles, CA
  4. 4Children's Oncology Group, Arcadia, CA
  5. 5Rhone-Poulenc Rorer Co., Collegeville, PA, U.S.A.
  1. Correspondence to: Vassilios I. Avramis, Ph.D., Childrens Hospital Los Angeles, Division of Hematology-Oncology, M.S. #57, 4650 Sunset Blvd., Los Angeles, CA 90027, U.S.A. Tel: (323) 669-2288, Fax: (323) 661-5058, e-mail: vavramis{at}chla.usc.edu

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 24, Issue 2C
March-April 2004
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Deamination of Glutamine is a Prerequisite for Optimal Asparagine Deamination by Asparaginases In Vivo (CCG-1961)
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 11 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Deamination of Glutamine is a Prerequisite for Optimal Asparagine Deamination by Asparaginases In Vivo (CCG-1961)
EDUARD H. PANOSYAN, RITA S. GRIGORYAN, IOANNIS A. AVRAMIS, NITA L. SEIBEL, PAUL S. GAYNON, STUART E. SIEGEL, HOWARD J. FINGERT, VASSILIOS I. AVRAMIS
Anticancer Research Mar 2004, 24 (2C) 1121-1126;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Deamination of Glutamine is a Prerequisite for Optimal Asparagine Deamination by Asparaginases In Vivo (CCG-1961)
EDUARD H. PANOSYAN, RITA S. GRIGORYAN, IOANNIS A. AVRAMIS, NITA L. SEIBEL, PAUL S. GAYNON, STUART E. SIEGEL, HOWARD J. FINGERT, VASSILIOS I. AVRAMIS
Anticancer Research Mar 2004, 24 (2C) 1121-1126;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Elevated Asparagine Biosynthesis Drives Brain Tumor Stem Cell Metabolic Plasticity and Resistance to Oxidative Stress
  • A Novel L-Asparaginase with low L-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias In Vivo
  • Asparagine Synthetase Polymorphisms and Toxicity and Efficacy of Asparaginases
  • The eIF2 Kinase GCN2 Is Essential for the Murine Immune System to Adapt to Amino Acid Deprivation by Asparaginase
  • Pharmacokinetics, pharmacodynamics, efficacy, and safety of a new recombinant asparaginase preparation in children with previously untreated acute lymphoblastic leukemia: a randomized phase 2 clinical trial
  • Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
  • Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia
  • Role of Glutamine Depletion in Directing Tissue-specific Nutrient Stress Responses to L-Asparaginase
  • Google Scholar

More in this TOC Section

  • Pembrolizumab and Quality of Life in Recurrent or Metastatic Head and Neck Cancer
  • Pretreatment Tumor Growth Rate and Clinical Outcomes in Advanced Non–small Cell Lung Cancer
  • Standard Clinical Characteristics Fail to Predict Mild Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire